Today: 6 March 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Sanofi Stock (SAN.PA, SNY) Slides After Tolebrutinib Double Setback: FDA Delay, Trial Miss, and Fresh Analyst Forecasts (Dec. 15, 2025)

Sanofi Stock (SAN.PA, SNY) Slides After Tolebrutinib Double Setback: FDA Delay, Trial Miss, and Fresh Analyst Forecasts (Dec. 15, 2025)

Sanofi shares fell about 4% in Paris on December 15 after the company reported a U.S. regulatory delay for tolebrutinib in non-relapsing secondary progressive MS and a failed Phase 3 trial in primary progressive MS. Sanofi will not seek approval for the latter indication. The FDA decision for nrSPMS is now expected after December 28, with further guidance by end of Q1 2026.
15 December 2025
···
Alibaba Stock (BABA) Today: Price, Latest News, Analyst Forecasts and 2026 Outlook as AI Spending Accelerates

Alibaba Stock (BABA) Today: Price, Latest News, Analyst Forecasts and 2026 Outlook as AI Spending Accelerates

Alibaba’s U.S.-listed shares traded near $155.68 on Dec. 15, 2025, within a volatile 52-week range of $80.06 to $192.67. The company has committed over $52 billion to AI and cloud infrastructure, raising concerns about rising capital expenditures outpacing revenue. Its Qwen AI app surpassed 10 million downloads in its first week and is now integrated into Quark, reaching over 200 million users in China.
15 December 2025
···
New Fortress Energy (NFE) Stock Today (Dec. 15, 2025): Debt Deadline, Puerto Rico Contract, and Analyst Forecasts Collide

New Fortress Energy (NFE) Stock Today (Dec. 15, 2025): Debt Deadline, Puerto Rico Contract, and Analyst Forecasts Collide

New Fortress Energy shares traded near $1.26 Monday, down 2.3%, as the company faces a December 15 deadline tied to a forbearance agreement on missed interest payments for its 2029 Notes. The agreement covers holders of over 70% of the notes and could trigger acceleration of debt if not extended or restructured. The stock sits near its 52-week low after a year of heavy volatility. Investors remain focused on debt negotiations.
15 December 2025
·
WORK Medical Technology Group LTD (NASDAQ: WOK) Stock: Today’s News, Nasdaq Compliance Risks, Dilution Watch, and Forecasts (Dec. 15, 2025)

WORK Medical Technology Group LTD (NASDAQ: WOK) Stock: Today’s News, Nasdaq Compliance Risks, Dilution Watch, and Forecasts (Dec. 15, 2025)

WORK Medical Technology Group (Nasdaq: WOK) traded around $0.11 on Dec. 15, 2025, after a 1-for-100 reverse split and repeated Nasdaq bid-price warnings. The stock’s 52-week range shows extreme volatility, distorted by the split and thin trading. A Nasdaq volatility halt was triggered on Dec. 10. The company supplies medical devices in China and exports to over 30 countries.
15 December 2025
·
Celestica Inc Stock (CLS) News Today: Why Shares Slid, What Analysts Forecast, and What to Watch Next

Celestica Inc Stock (CLS) News Today: Why Shares Slid, What Analysts Forecast, and What to Watch Next

Celestica shares fell 12.78% to $306.50 on December 12 amid a broader tech selloff linked to concerns over AI valuations and rising borrowing costs. The stock rebounded in early pre-market trading December 15, indicated at $312.10. B. Riley Wealth Advisors disclosed a new stake of 11,319 shares, while director Laurette T. Koellner bought 6,000 shares in October. Institutional investors hold about 67% of Celestica shares.
15 December 2025
·
ZIM Stock (NYSE: ZIM) in Focus: Takeover Bids, Proxy Fight, Dividend Signals, and Analyst Forecasts (Dec. 15, 2025)

ZIM Stock (NYSE: ZIM) in Focus: Takeover Bids, Proxy Fight, Dividend Signals, and Analyst Forecasts (Dec. 15, 2025)

ZIM Integrated Shipping shares fell 5.4% to $18.76 on Dec. 15, 2025, amid takeover speculation and a pending shareholder vote. The board confirmed a strategic review after receiving a non-binding acquisition proposal from CEO Eli Glickman and Rami Ungar. Reports say MSC and Hapag-Lloyd have also submitted bids. Any sale would require shareholder and Israeli government approval.
15 December 2025
···
Milestone Pharmaceuticals (MIST) Stock: FDA Approval of CARDAMYST, Launch Timeline, and Analyst Forecasts (Dec. 15, 2025)

Milestone Pharmaceuticals (MIST) Stock: FDA Approval of CARDAMYST, Launch Timeline, and Analyst Forecasts (Dec. 15, 2025)

The FDA approved Milestone Pharmaceuticals’ CARDAMYST (etripamil) nasal spray for adults with paroxysmal supraventricular tachycardia, marking the first new U.S. PSVT treatment in over 30 years. The company targets retail availability in Q1 2026. Shares showed sharp volatility after the announcement. Milestone scheduled an investor call for December 15 to discuss launch plans.
15 December 2025
·
GE Aerospace Stock (NYSE: GE) News Today: Citi’s $386 Target, FAA LEAP Inspections, Navy Orders, and What to Watch Into 2026

GE Aerospace Stock (NYSE: GE) News Today: Citi’s $386 Target, FAA LEAP Inspections, Navy Orders, and What to Watch Into 2026

GE Aerospace shares rose about 4% to $299.81, following Citigroup’s initiation of coverage with a Buy rating and $386 target. The company also secured orders to supply LM2500 engines for two U.S. Navy destroyers. Meanwhile, the FAA issued a new airworthiness directive for certain CFM LEAP-1A engines after reports of blade cracks.
15 December 2025
···
Micron Technology (MU) Stock News and Forecast — Dec. 15, 2025: Earnings Preview, AI Memory Crunch, and Wall Street Price Targets

Micron Technology (MU) Stock News and Forecast — Dec. 15, 2025: Earnings Preview, AI Memory Crunch, and Wall Street Price Targets

Micron shares fell 6.7% to $241.14 ahead of its fiscal Q1 2026 earnings report set for Dec. 17. Options markets are pricing in a post-earnings move of about ±10.8%. Wall Street expects revenue near $12.6–$12.8 billion and EPS around $3.84–$3.91, driven by strong AI-related demand and higher memory prices.
15 December 2025
··
Incannex Healthcare (NASDAQ: IXHL) Stock: FDA Fast Track Catalyst, Nasdaq Compliance Clock, and the Latest Forecasts as of Dec. 15, 2025

Incannex Healthcare (NASDAQ: IXHL) Stock: FDA Fast Track Catalyst, Nasdaq Compliance Clock, and the Latest Forecasts as of Dec. 15, 2025

Incannex Healthcare shares traded near $0.42 early December 15, 2025, after the FDA granted Fast Track designation to its lead sleep apnea drug IHL-42X on December 3. The company also received a Nasdaq bid-price compliance extension to April 2026 and saw updated research coverage from Stonegate Capital Partners in November. Analyst coverage remains limited.
15 December 2025
·
ImmunityBio (IBRX) Stock in Focus on Dec. 15, 2025: EMA’s ANKTIVA Nod, Analyst Targets, and What Comes Next

ImmunityBio (IBRX) Stock in Focus on Dec. 15, 2025: EMA’s ANKTIVA Nod, Analyst Targets, and What Comes Next

The European Medicines Agency’s CHMP issued a positive opinion recommending conditional marketing authorization for ImmunityBio’s Anktiva plus BCG in BCG-unresponsive non-muscle invasive bladder cancer. IBRX shares closed at $2.36 on Dec. 12, up 7.76% on heavy volume, and traded near $2.39 pre-market Dec. 15. The European Commission has not yet given final approval.
15 December 2025
··
cbdMD (YCBD) Stock News Today (Dec. 15, 2025): Why Shares Are Volatile, What the Latest Filings Say, and the Updated YCBD Stock Forecast

cbdMD (YCBD) Stock News Today (Dec. 15, 2025): Why Shares Are Volatile, What the Latest Filings Say, and the Updated YCBD Stock Forecast

cbdMD shares surged after the company regained full NYSE American compliance, with the “.BC” flag removed as of December 8. Preliminary FY2025 results show net sales steady near $19.2 million and net loss narrowing to $1.9–$2.1 million. Broader sector momentum followed reports of potential cannabis rescheduling under a Trump administration.
15 December 2025
·
STMicroelectronics (STM) Stock News and Forecasts: Starlink Chips, €1B EIB Funding, and What to Watch Into 2026 (Dec. 15, 2025)

STMicroelectronics (STM) Stock News and Forecasts: Starlink Chips, €1B EIB Funding, and What to Watch Into 2026 (Dec. 15, 2025)

STMicroelectronics said it has shipped over 5 billion RF chips to SpaceX for Starlink terminals, with deliveries expected to double in two years. The company’s stock traded near $26.00 on December 15, 2025, little changed after the news. The update follows ST’s recent €1 billion credit line from the European Investment Bank to boost R&D and manufacturing in Europe.
15 December 2025
···
IREN Limited Stock (NASDAQ: IREN): Latest News, Financing Update, and Analyst Forecasts as of Dec. 15, 2025

IREN Limited Stock (NASDAQ: IREN): Latest News, Financing Update, and Analyst Forecasts as of Dec. 15, 2025

IREN Limited shares remain volatile after the company secured a $9.7 billion, five-year AI cloud contract with Microsoft, announced November 3. Early December saw IREN close a major financing round, raising concerns about dilution despite strengthening its balance sheet. Investors are watching execution of the Microsoft deal and the impact of new capital structure after a sharp pullback in December trading. No new company updates were issued on December 15.
15 December 2025
·
Tesla Stock (TSLA) News Today: Driverless Robotaxi Tests, Analyst Price Targets, and 2026 Forecasts (Dec. 15, 2025)

Tesla Stock (TSLA) News Today: Driverless Robotaxi Tests, Analyst Price Targets, and 2026 Forecasts (Dec. 15, 2025)

Tesla shares closed at $458.96, up 2.7%, after a volatile session driven by news of robotaxi testing in Austin without safety monitors. CEO Elon Musk confirmed the company is running vehicles with no occupants as part of its next phase. The Austin robotaxi fleet has grown to 31 vehicles, up from 29 last month. The move intensifies debate over Tesla’s value as an autonomy platform versus a traditional automaker.
15 December 2025
···
NVIDIA Stock (NVDA) News Today: China H200 Export Shift, Blackwell Ramp, and Wall Street Forecasts (December 15, 2025)

NVIDIA Stock (NVDA) News Today: China H200 Export Shift, Blackwell Ramp, and Wall Street Forecasts (December 15, 2025)

NVIDIA shares traded near $175 after a sharp pullback, as the U.S. approved exports of H200 AI chips to China with a 25% fee. The Trump administration’s move drew political backlash in Washington and uncertainty in Beijing. NVIDIA told Chinese clients it may increase H200 production after orders outpaced supply. The Philadelphia Semiconductor Index posted its weakest session since October 10.
15 December 2025
··
Oriental Culture Holding LTD Stock (NASDAQ: OCG) in Free-Fall After $200M ATM Filing: News, Forecast Scenarios, and What to Watch (Dec. 15, 2025)

Oriental Culture Holding LTD Stock (NASDAQ: OCG) in Free-Fall After $200M ATM Filing: News, Forecast Scenarios, and What to Watch (Dec. 15, 2025)

Oriental Culture Holding (NASDAQ: OCG) shares plunged from over $10 on December 9 to about $0.22 by December 12, after extreme intraday swings and heavy trading volume. The volatility followed the company’s announcement of a $200 million at-the-market equity offering with A.G.P./Alliance Global Partners, disclosed in an SEC filing on December 11.
15 December 2025
·
iRobot Corporation Stock (IRBT) in Focus: Chapter 11 Bankruptcy, Picea Buyout Plan, and What It Means for Shareholders (Dec. 15, 2025)

iRobot Corporation Stock (IRBT) in Focus: Chapter 11 Bankruptcy, Picea Buyout Plan, and What It Means for Shareholders (Dec. 15, 2025)

iRobot filed for pre-packaged Chapter 11 bankruptcy on December 14–15, 2025, and agreed to transfer ownership to Shenzhen PICEA Robotics. The company expects all existing equity to be cancelled, with no recovery for common shareholders, and plans to go private. IRBT shares traded around $4.32 after the announcement, far below their $161.16 all-time high.
15 December 2025
···
Canopy Growth Corporation Stock (CGC) Surges on Trump Marijuana Rescheduling Reports: Latest News, Forecasts, and What Comes Next (Dec. 15, 2025)

Canopy Growth Corporation Stock (CGC) Surges on Trump Marijuana Rescheduling Reports: Latest News, Forecasts, and What Comes Next (Dec. 15, 2025)

Canopy Growth shares surged as much as 17.9% in early European trading Monday, extending Friday’s 54% jump, after reports that President Trump may reclassify marijuana as a Schedule III drug. Trading volume spiked, with speculation focused on potential U.S. federal reform and its impact on cannabis industry taxes. No final decision has been confirmed by the White House.
15 December 2025
··
1 … 450 451 452 453 454 … 584
Go toTop